Prebiotic potential of barley derived β-glucan at low intake levels: A randomised, double-blinded, placebo-controlled clinical study

Abstract

Abstract This randomised, double-blinded, placebo-controlled clinical study aimed to evaluate the in vivo prebiotic potential of barley β-glucan. Fifty-two healthy volunteers aged 39–70 years were randomly assigned to consume daily a cake containing 0.75 g of barley β-glucan or a placebo for 30 d. Stool samples were collected before, during and 2 weeks after the intervention for bacterial enumeration. Gastrointestinal side effects were recorded during the treatment period. In older subjects (⩾50 years old), barley β-glucan induced a strong bifidogenic effect and an increase of bifidobacteria into traceable range in cases of no detectable baseline levels. A concurrent significant increase in bacteroides was also observed in this age group. Ingestion of the experimental food resulted in no undesirable gastrointestinal side effects in older subjects. We concluded that the daily intake of a cake containing barley β-glucan is well-tolerated and demonstrated significant bifidogenic properties in older healthy volunteers consuming their usual diets.